American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

SYNLOGIC, INC. (SYBX)

$0.67 -5.80% OTC: SYBX · 15-min delayed

WINCHESTER, Massachusetts
Public · OTC: SYBX

Visit website Follow

$0Revenue · FY2025

-$1.0MNet income

SYBXOTC

About SYNLOGIC, INC.

SYNLOGIC INC

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: SYBX
Headquarters: WINCHESTER, Massachusetts
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: SYBX OTC
SEC CIK: 1527599
EIN: 261824804
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show Synlogic, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/synlogic-inc/"><img src="https://americancompanies.com/badge/synlogic-inc.svg" alt="Synlogic, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow SYNLOGIC, INC. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $0
Net income: -$1.0M
Total assets: $15.4M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

FY2021

FY2022

FY2023

FY2024

FY2025

Revenue Net income

FY 2025

Financial statements

Income statement

Revenue: $0
Operating expenses: $4.0M
Operating income: -$4.0M
Income tax: $0
Net income: -$1.0M
EPS (basic): $-0.08
EPS (diluted): $-0.08

Balance sheet

Total assets: $15.4M
Current assets: $15.4M
Total liabilities: $3.6M
Current liabilities: $3.6M
Shareholders’ equity: $11.9M

Cash flow

Operating cash flow: -$4.4M
Investing cash flow: $167.0K
Financing cash flow: $4.2M
Net cash flow: $0

Statements via Polygon.io (SEC filings)

OTC: SYBX

$0.67 -5.80%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.56 $1.83

52-week range

EPS (diluted): $-0.08
Open: —
Day range: –
Prev close: —
Volume: —

Synlogic, Inc. (SYBX) Stock Price

Reported a net loss of $1.0M in FY2025.
Trading 63% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review SYNLOGIC, INC..

Write a review

Newsroom

News about SYNLOGIC, INC.

Synlogic Reports First Quarter 2024 Financial Results GlobeNewswire Inc. · 2024-05-14 Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates Zacks Investment Research · 2024-03-19 Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Misses Revenue Estimates Zacks Investment Research · 2024-03-13 Synlogic Adopts Limited Duration Stockholders Rights Plan GlobeNewswire Inc. · 2024-02-20 Crude Oil Moves Higher; Newell Brands Issues Weak Outlook Benzinga · 2024-02-09 Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session Benzinga · 2024-02-09

News & sentiment via Polygon.io

FAQ

Synlogic, Inc.: frequently asked questions

Is Synlogic, Inc. an American company?

Synlogic, Inc. is a US-based company headquartered in Winchester, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Synlogic, Inc. headquartered?

Synlogic, Inc. is headquartered in Winchester, Massachusetts, United States.

Is Synlogic, Inc. publicly traded?

Yes — Synlogic, Inc. is a publicly traded company. Its stock trades under the ticker symbol SYBX on the OTC.

What does Synlogic, Inc. do?

Synlogic, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore